Table 1.
Commercially available gadolinium-based contrast agents (GBCAs) in Europe approved during pregnancy.
| Trade Name | Marketing Authorisation Holder | Compound | Chemical Structure | Use |
|---|---|---|---|---|
| Dotarem® | Guerbet Diagnostic Imaging | Gadoterate meglumine | Macrocyclic | Intraarticular/Intravenous |
| Gadovist® | Bayer Pharmaceuticals | Gadobutrolo | Macrocyclic | Intravenous |
| Magnevist® | Bayer Pharmaceuticals | Gadopentetate dimeglumine | Linear | Intraarticular |
| Multihance® | Bracco Imaging | Gadobenate dimeglumine | Linear | Intravenous |
| Primovist® | Bayer Pharmaceuticals | Gadoxetate disodium | Linear | Intravenous |
| Prohance® | Bracco Imaging | Gadoteridol | Macrocyclic | Intravenous |